Page last updated: 2024-11-01

ondansetron and Pulmonary Hypertension

ondansetron has been researched along with Pulmonary Hypertension in 2 studies

Ondansetron: A competitive serotonin type 3 receptor antagonist. It is effective in the treatment of nausea and vomiting caused by cytotoxic chemotherapy drugs, including cisplatin, and has reported anxiolytic and neuroleptic properties.

Research Excerpts

ExcerptRelevanceReference
" We treated the pain of acute arthritis with the specific 5-hydroxytryptamine subtype 3 receptor antagonist ondansetron."7.69Treatment of acute gouty arthritis with the 5-hydroxytryptamine antagonist ondansetron. ( Ramadori, G; Schwörer, H, 1994)
" We treated the pain of acute arthritis with the specific 5-hydroxytryptamine subtype 3 receptor antagonist ondansetron."3.69Treatment of acute gouty arthritis with the 5-hydroxytryptamine antagonist ondansetron. ( Ramadori, G; Schwörer, H, 1994)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Schwörer, H1
Ramadori, G1
Lawhorn, S1
Lawhorn, CD1
Davison, C1

Other Studies

2 other studies available for ondansetron and Pulmonary Hypertension

ArticleYear
Treatment of acute gouty arthritis with the 5-hydroxytryptamine antagonist ondansetron.
    The Clinical investigator, 1994, Volume: 72, Issue:10

    Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Gouty; Colchicine; Contraindications; Eso

1994
Ondansetron eliminates nausea and vomiting associated with prostacyclin in a patient awaiting lung transplantation.
    The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation, 1997, Volume: 16, Issue:4

    Topics: Adult; Antiemetics; Antihypertensive Agents; Epoprostenol; Female; Humans; Hypertension, Pulmonary;

1997